Literature DB >> 17200091

Inhaled milrinone: a new alternative in cardiac surgery?

André Y Denault1, Yoan Lamarche, Pierre Couture, Francois Haddad, Jean Lambert, Jean-Claude Tardif, Louis P Perrault.   

Abstract

The administration of milrinone through inhalation has been studied in only a few animal and human studies. Compared to the intravenous administration, inhaled milrinone has been shown to reduce pulmonary artery pressure without systemic hypotension. Therefore, this approach could represent an alternative to nitric oxide. This current state of knowledge of intravenous and inhaled milrinone is presented and summarized.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17200091     DOI： 10.1177/1089253206294400

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN： 1089-2532


  5 in total

1.  A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.

Authors:  Kassiani Theodoraki; Apostolos Thanopoulos; Panagiota Rellia; Evangelos Leontiadis; Dimitrios Zarkalis; Konstantinos Perreas; Theophani Antoniou
Journal:  Heart Vessels       Date:  2017-07-17       Impact factor: 2.037

2.  Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery.

Authors:  Gregory A Fleming; Katherine T Murray; Chang Yu; John G Byrne; James P Greelish; Michael R Petracek; Steven J Hoff; Stephen K Ball; Nancy J Brown; Mias Pretorius
Journal:  Circulation       Date:  2008-09-29       Impact factor: 29.690

3.  Inhaled milrinone attenuates experimental acute lung injury.

Authors:  Moritz Bueltmann; Xiang Kong; Michael Mertens; Ning Yin; Jun Yin; Zhongmin Liu; Andreas Koster; Hermann Kuppe; Wolfgang M Kuebler
Journal:  Intensive Care Med       Date:  2008-10-30       Impact factor: 17.440

4.  A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.

Authors:  André Y Denault; Jean S Bussières; Ramiro Arellano; Barry Finegan; Paul Gavra; François Haddad; Anne Q N Nguyen; France Varin; Annik Fortier; Sylvie Levesque; Yanfen Shi; Mahsa Elmi-Sarabi; Jean-Claude Tardif; Louis P Perrault; Jean Lambert
Journal:  Can J Anaesth       Date:  2016-07-28       Impact factor: 6.713

Review 5.  Inhaled therapy for the management of perioperative pulmonary hypertension.

Authors:  C A Thunberg; S T Morozowich; Harish Ramakrishna
Journal:  Ann Card Anaesth       Date:  2015 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.